Total medical devices industry Cross Border venture financing deals worth $1.18bn were announced globally in Q1 2021, led by $100m venture financing of NewMed Medical , according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 11.3% over the previous quarter and a drop of 6.4% when compared with the last four-quarter average, which stood at $1.26bn.
Comparing cross border deals value in different regions of the globe, North America held the top position, with total announced deals worth $715.46m in the period. At the country level, the US topped the list in terms of deal value at $626.67m.
In terms of volumes, North America emerged as the top region for medical devices industry cross border venture financing deals globally, followed by Europe and then Middle East and Africa.
The top country in terms of cross border venture financing deals activity in Q1 2021 was the US with 25 deals, followed by Israel with ten and Canada with six.
In 2021, at the end of , cross border venture financing deals worth $1.18bn were announced globally in medical devices industry, marking an increase of 9.9% year on year.
Cross Border venture financing deals in medical devices industry in Q1 2021: Top deals
The top five cross border venture financing deals in medical devices industry accounted for 34.4% of the overall value during Q1 2021.
The combined value of the top five cross border venture financing deals stood at $405m, against the overall value of $1.18bn recorded for the quarter.
The top five medical devices industry cross border venture financing deals of Q1 2021 tracked by GlobalData were: